Meet the challenge

WHAT IS IT ABOUT?

We want to find scalable technology-based solutions that improves secondary prevention, diagnosis, access to treatment and/or monitoring of Colombians with cardiovascular diseases, which can also be implemented within the health system.

WHAT IS THE PROBLEM?

Today we are facing another silent pandemic, which are the first cause of global deaths(1-3): Cardiovascular Disease, including: ASCVD and Heart Failure.

YOUR MISSION!

Beat the pace of innovation to find the solution that will help prevent cardiovascular disease from being the leading cause of death in the world(1-3).

Download all the supporting information and the requirements to participate in the challenge.

Requirements

Watch again

2020

DESIGN YOUR SOLUTION

Your project may provide one or more solutions for the different steps and categories:

Step 1
Your project may provide one or more solutions from the various steps and categories for: 
  • Atherosclerotic cardiovascular disease (ASCVD)
  • Heart failure
Note: you can choose one or both
Step 2
Choose the category of the disease that your project will impact:
  • Secondary prevention
  • Diagnosis
  • Access to treatment
  • Monitoring
Note: you can choose one or all
Step 3
Your idea must adhere to the following categories:​
  • Technological development
  • Technology readiness levels TRL4*.

BENEFITS

With a total funding of up to
30,000 USD for the selected proposal(s).

Validation in local settings of a minimum viable product, prototype or pilot model.

Networking and socialization activities with potential beneficiary.

Mentorship by the organizer and allies for the scalling up and consolidation of the chosen solution selected in Colombia.

Registrations

Open from February 15th, 2021

BEAT THE PACE OF INNOVATION BY REGISTERING YOUR PROJECT HERE:

In alliance with:

Colobia Emprende
Innpuls
Sociedad Colombiana de Cardiología & cirugía cardiovascular
acmi
Universidad el bosque
HUB IEX
Connect
Connect

References:

1. World Health Organization. Cardiovascular diseases fact sheet 2017 [Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)].

2. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260-344.

3. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151-210.

  

Novartis de Colombia S.A: Calle 93B No. 16-31 PBX 654 44 44 Bogotá D.C. Novartis de Colombia S.A. Novartis Pharma, AG de Basilea, Suiza ® =Marca registrada. Material exclusivo para uso de público general. Cualquier información sobre productos que no sean de Novartis se basa en información disponible al momento de esta presentación. Mayor información en el Departamento Medico de Novartis de Colombia S.A. Tel. 6544444 o al correo: informacion.cientifica@novartis.com. No se autoriza la grabación o toma de fotografías del material y tampoco difusión por medios no autorizados por Novartis. Código de aprobación P3: AN2103026416. Fecha de aprobación: 2 de marzo de 2021 Fecha de caducidad: 31 de diciembre de 2022